Guide to use of ferumoxytol for hepatic vascular assessment as part of dual contrast MRI

Risha Shah, Arielle VanSyckel, Andrada Roxana Popescu, Cynthia K. Rigsby, Lindsay Marie Griffin*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Magnetic resonance imaging (MRI) assessment of hepatic vasculature can be challenging in the setting of liver disease and liver lesions. The widely used hepatobiliary contrast agent gadoxetate is an extracellular contrast agent that provides excellent soft tissue characterization but has limitations as a vascular contrast agent. Ferumoxytol is an iron oxide nanoparticle with superparamagnetic properties that can be used as blood pool contrast agent to provide dedicated vascular assessment. We provide a detailed protocol for evaluation of pediatric liver vasculature using ferumoxytol, after imaging of the parenchyma with gadoxetate. We provide multiple examples and discuss practical considerations when incorporating ferumoxytol into practice.

Original languageEnglish (US)
JournalPediatric radiology
DOIs
StateAccepted/In press - 2023

Keywords

  • Angiography
  • Blood pool imaging
  • Ferumoxytol
  • Liver tumor
  • Magnetic resonance

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Guide to use of ferumoxytol for hepatic vascular assessment as part of dual contrast MRI'. Together they form a unique fingerprint.

Cite this